Novartis Gene Therapies, Inc.
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
- DOL LCA filings
- 16
- DOL-certified
- 100%
- Median offered wage
- $95,536
East Hanover, NJ NAICS: 32541
How many H-1B LCA filings list Novartis Gene Therapies, Inc.?
U.S. Department of Labor's OFLC discloses 16 Labor Condition Application filings naming Novartis Gene Therapies, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
How many H-1B petitions has USCIS approved for Novartis Gene Therapies, Inc.?
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 18 H-1B petitions naming Novartis Gene Therapies, Inc. through FY2023, and approved nearly every one of them: 100% approved (18 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Novartis Gene Therapies, Inc. is listed in 16 DOL LCA filings, more filings than 90% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $95,536. This is not a USCIS approval, hiring, or sponsorship ranking.
- 16
- DOL LCA filings, FY2023–FY2026
- 100%
- DOL-certified
- $95,536
- median offered wage
- Top 10%
- of employer filers by volume
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in East Hanover, NJ.
Novartis Gene Therapies, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
16 13444th of 122824 higher than 109,380 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
LCA filing shape · Novartis Gene Therapies, Inc.
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $73,050–$115,482 .
Title concentration
- Manufacturing Quality Assurance Specialist 4 · 25% · $88,546
- Specialist, Quality Control 3 · 18.8% · $100,748
- Senior Engineer, Manufacturing Science 2 · 12.5% · $115,482
- Quality Control Specialist 2 · 12.5% · $75,691
- Sr Engineer, Manufacturing Science &Tech 1 · 6.3% · $112,757
Worksite counties
- DURHAM, NC 9 · 81.8%
- LAKE, IL 2 · 18.2%
DOL LCA release change
What changed between the two LCA fiscal years
- Novartis Gene Therapies, Inc. disclosed 4 H-1B LCA filings in FY2025 after zero filings in FY2024.
Thin filer, multi-state worksites
Only 16 LCAs, but worksites already span 2 states (NC, IL). HQ East Hanover, NJ · DOL cert 100%.
Geographic Distribution
Where Novartis Gene Therapies, Inc. places H-1B workers across the United States
Recent LCA Filings
Latest H-1B labor condition applications filed by Novartis Gene Therapies, Inc.
| Job Title | Location | Salary | Status | Year |
|---|---|---|---|---|
| Manufacturing Quality Assurance Specialist | Durham, NC | $98,218 | Certified | FY2026 |
| Quality Control Specialist | Durham, NC | $75,691 | Certified | FY2026 |
| Manufacturing Quality Assurance Specialist | Durham, NC | $98,218 | Certified | FY2026 |
| Quality Control Specialist | Durham, NC | $75,691 | Certified | FY2026 |
| Sr Engineer, Manufacturing Science &Tech | Durham, NC | $112,757 | Certified | FY2025 |
| Specialist, Quality Control | Durham, NC | $84,344 | Certified | FY2025 |
| Specialist, Quality Control IT | Durham, NC | $112,320 | Certified | FY2025 |
| Senior Specialist, Quality Assurance | Durham, NC | $92,206 | Certified | FY2025 |
| Manufacturing Quality Assurance Specialist | Durham, NC | $78,874 | Certified | FY2023 |
| Manufacturing Quality Assurance Specialist | Durham, NC | $78,874 | Certified | FY2023 |
| Engineer, Manufacturing Science and Technology | Durham, NC | $99,466 | Certified | FY2023 |
| Senior Analyst, Quality Control | Durham, NC | $73,050 | Certified | FY2023 |
| Senior Engineer, Manufacturing Science | Libertyville, IL | $115,482 | Certified | FY2023 |
| Specialist, Quality Control | Durham, NC | $108,950 | Certified | FY2023 |
| Senior Engineer, Manufacturing Science | Libertyville, IL | $115,482 | Certified | FY2023 |
| Specialist, Quality Control | Durham, NC | $108,950 | Certified | FY2023 |
Nationwide peers near Novartis Gene Therapies, Inc.'s 16-LCA band
Cross-state DOL neighbors for Novartis Gene Therapies, Inc. - LCA filing-count and offered-wage axes, outside NJ.
Similar LCA filing volume
Nearest cross-state employer filers by LCA filing count (16 here; floor ≥10 LCA filings).
Similar avg offered wage
Cross-state employer filers with a comparable average listed offered wage ($95,536 here).
Disclaimer: Informational only, not professional advice.
Read with Novartis Gene Therapies, Inc.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-LOCK · WAGE-BELOW.
ABS(total_petitions) peer at 16 LCAs (Δ 0 heavier vs Novartis Gene Therapies, Inc.); CERT-SOFT · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-BELOW.
ABS(total_petitions) peer at 16 LCAs (Δ 0 heavier vs Novartis Gene Therapies, Inc.); CERT-LOCK · WAGE-PAR vs this page's MICRO-BOOK · CERT-LOCK · WAGE-BELOW.
ABS(total_petitions) peer at 16 LCAs (Δ 0 heavier vs Novartis Gene Therapies, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-BELOW.
ABS(total_petitions) peer at 16 LCAs (Δ 0 heavier vs Novartis Gene Therapies, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-BELOW.
NJ pole at 39,678 LCAs stamps MEGA-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Novartis Gene Therapies, Inc.'s MICRO-BOOK.
Open the NJ state board after the ABS peers. Novartis Gene Therapies, Inc. stamps MICRO-BOOK · CERT-LOCK inside that worksite mix.
Novartis Gene Therapies, Inc.'s WAGE-BELOW · MICRO-BOOK stamps sit mid-band. Wage levels I-IV explain the floor behind the offer.
What to do with this profile
Use the DOL LCA record for Novartis Gene Therapies, Inc. to compare filing volume and offered wages, not USCIS outcomes.
- Novartis Gene Therapies, Inc. filed 16 LCAs in the indexed extract (100% certified in-file). That volume ranks higher than 90% of employer filers.
- Compare offered wages and certification rates against 6 same-state filers on the chart above. Jump to compare
- See how other employers in NJ rank on LCA filing volume this vintage. NJ filers
- Read what an LCA filing records versus a USCIS petition approval. LCA vs petition
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.